{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T16:09:58Z","timestamp":1787155798990,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T00:00:00Z","timestamp":1549238400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81300746"],"award-info":[{"award-number":["81300746"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81300806"],"award-info":[{"award-number":["81300806"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010032","name":"Foundation of Shanghai Municipal Commission of Health and Family Planning","doi-asserted-by":"publisher","award":["20174Y0186"],"award-info":[{"award-number":["20174Y0186"]}],"id":[{"id":"10.13039\/501100010032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","award":["16ZR1405200"],"award-info":[{"award-number":["16ZR1405200"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12886-019-1056-7","type":"journal-article","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T12:03:23Z","timestamp":1549281803000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Evaluation of the antioxidant effects of different histone deacetylase inhibitors (HDACis) on human lens epithelial cells (HLECs) after UVB exposure"],"prefix":"10.1186","volume":"19","author":[{"given":"Xiaodi","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianfang","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,4]]},"reference":[{"issue":"1","key":"1056_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1517\/13543776.2013.736493","volume":"23","author":"V Carafa","year":"2013","unstructured":"Carafa V, Miceli M, Altucci L, Nebbioso A. Histone deacetylase inhibitors: a patent review (2009 - 2011). Expert Opin Ther Pat. 2013;23(1):1\u201317.","journal-title":"Expert Opin Ther Pat"},{"issue":"8","key":"1056_CR2","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H","volume":"20","author":"MH Kuo","year":"1998","unstructured":"Kuo MH, Allis CD. Roles of histone acetyltransferases and deacetylases in gene regulation. BioEssays. 1998;20(8):615\u201326.","journal-title":"BioEssays"},{"key":"1056_CR3","doi-asserted-by":"crossref","unstructured":"de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 2003; 370(Pt 3):737\u2013749.","DOI":"10.1042\/bj20021321"},{"issue":"9","key":"1056_CR4","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2174\/1389557515666150521162237","volume":"15","author":"J Behera","year":"2015","unstructured":"Behera J, Jayprakash V, Sinha BN. Histone deacetylase inhibitors: a review on class-I specific inhibition. Mini Rev Med Chem. 2015;15(9):731\u201350.","journal-title":"Mini Rev Med Chem"},{"issue":"4","key":"1056_CR5","doi-asserted-by":"crossref","first-page":"383","DOI":"10.55782\/ane-2014-2001","volume":"74","author":"M Ziemka-Nalecz","year":"2014","unstructured":"Ziemka-Nalecz M, Zalewska T. Neuroprotective effects of histone deacetylase inhibitors in brain ischemia. Acta Neurobiol Exp (Wars). 2014;74(4):383\u201395.","journal-title":"Acta Neurobiol Exp (Wars)"},{"key":"1056_CR6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/978-1-61779-328-8_32","volume":"793","author":"E Soragni","year":"2011","unstructured":"Soragni E, Xu C, Cooper A, Plasterer HL, Rusche JR, Gottesfeld JM. Evaluation of histone deacetylase inhibitors as therapeutics for neurodegenerative diseases. Methods Mol Biol. 2011;793:495\u2013508.","journal-title":"Methods Mol Biol"},{"issue":"9","key":"1056_CR7","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1517\/13543784.2010.510514","volume":"19","author":"PA Marks","year":"2010","unstructured":"Marks PA. The clinical development of histone deacetylase inhibitors as targeted anticancer drugs. Expert Opin Investig Drugs. 2010;19(9):1049\u201366.","journal-title":"Expert Opin Investig Drugs"},{"issue":"5","key":"1056_CR8","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.drudis.2013.11.012","volume":"19","author":"FJ Dekker","year":"2014","unstructured":"Dekker FJ, van den Bosch T, Martin NI. Small molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseases. Drug Discov Today. 2014;19(5):654\u201360.","journal-title":"Drug Discov Today"},{"key":"1056_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/srep34704","volume":"6","author":"X Rong","year":"2016","unstructured":"Rong X, Qiu X, Jiang Y, Li D, Xu J, Zhang Y, Lu Y. Effects of histone acetylation on superoxide dismutase 1 gene expression in the pathogenesis of senile cataract. Sci Rep. 2016;6:34704.","journal-title":"Sci Rep"},{"issue":"1","key":"1056_CR10","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.bbrc.2014.11.079","volume":"456","author":"X Wang","year":"2015","unstructured":"Wang X, Xu J, Wang H, Wu L, Yuan W, Du J, Cai S. Trichostatin a, a histone deacetylase inhibitor, reverses epithelial-mesenchymal transition in colorectal cancer SW480 and prostate cancer PC3 cells. Biochem Biophys Res Commun. 2015;456(1):320\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"1056_CR11","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1089\/ars.2014.5853","volume":"21","author":"JZ Selin","year":"2014","unstructured":"Selin JZ, Lindblad BE, Rautiainen S, Micha\u00eblsson K, Morgenstern R, Bottai M, Basu S, Wolk A. Are increased levels of systemic oxidative stress and inflammation associated with age-related cataract? Antioxid Redox Signal. 2014;21(5):700\u20134.","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"1056_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/ICL.0b013e31821ec4f2","volume":"37","author":"SD Varma","year":"2011","unstructured":"Varma SD, Kovtun S, Hegde KR. Role of ultraviolet irradiation and oxidative stress in cataract formation-medical prevention by nutritional antioxidants and metabolic agonists. Eye Contact Lens. 2011;37(4):233\u201345.","journal-title":"Eye Contact Lens"},{"key":"1056_CR13","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13148-016-0229-y","volume":"8","author":"Y Wang","year":"2016","unstructured":"Wang Y, Li F, Zhang G, Kang L, Guan H. Ultraviolet-B induces ERCC6 repression in lens epithelium cells of age-related nuclear cataract through coordinated DNA hypermethylation and histone deacetylation. Clin Epigenetics. 2016;8:62.","journal-title":"Clin Epigenetics"},{"issue":"6","key":"1056_CR14","doi-asserted-by":"publisher","first-page":"711","DOI":"10.4161\/auto.6.6.12397","volume":"6","author":"J Li","year":"2010","unstructured":"Li J, Liu R, Lei Y, Wang K, Lau QC, Xie N, Zhou S, Nie C, Chen L, Wei Y, Huang C. Proteomic analysis revealed association of aberrant ROS signaling with suberoylanilide hydroxamic acid-induced autophagy in Jurkat T-leukemia cells. Autophagy. 2010;6(6):711\u201324.","journal-title":"Autophagy"},{"issue":"13","key":"1056_CR15","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1111\/bph.13788","volume":"174","author":"J Qian","year":"2017","unstructured":"Qian J, Zhu W, Lu M, Ni B, Yang J. D-\u03b2-hydroxybutyrate promotes functional recovery and relieves pain hypersensitivity in mice with spinal cord injury. Br J Pharmacol. 2017;174(13):1961\u201371.","journal-title":"Br J Pharmacol"},{"key":"1056_CR16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neuroscience.2017.09.056","volume":"366","author":"X Wang","year":"2017","unstructured":"Wang X, Wu X, Liu Q, Kong G, Zhou J, Jiang J, Wu X, Huang Z, Su W, Zhu Q. Ketogenic metabolism inhibits histone deacetylase (HDAC) and reduces oxidative stress after spinal cord injury in rats. Neuroscience. 2017;366:36\u201343.","journal-title":"Neuroscience"},{"issue":"10","key":"1056_CR17","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1002\/jcb.24569","volume":"114","author":"Y Wang","year":"2013","unstructured":"Wang Y, Chen T, Yan H, Qi H, Deng C, Ye T, Zhou S, Li FR. Role of histone deacetylase inhibitors in the aging of human umbilical cord mesenchymal stem cells. J Cell Biochem. 2013;114(10):2231\u20139.","journal-title":"J Cell Biochem"},{"issue":"Suppl 2","key":"1056_CR18","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1471-4159.2012.07949.x","volume":"123","author":"S Baltan","year":"2012","unstructured":"Baltan S. Histone deacetylase inhibitors preserve function in aging axons. J Neurochem. 2012;123(Suppl 2):108\u201315.","journal-title":"J Neurochem"},{"issue":"11","key":"1056_CR19","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.1167\/iovs.16-19242","volume":"57","author":"B Li","year":"2016","unstructured":"Li B, Zhou J, Zhang G, Wang Y, Kang L, Wu J, Chen J, Guan H. Relationship between the altered expression and epigenetics of GSTM3 and age-related cataract. Invest Ophthalmol Vis Sci. 2016;57(11):4721\u201332.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"1056_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.tem.2013.09.002","volume":"25","author":"JC Newman","year":"2014","unstructured":"Newman JC, Verdin E. Ketone bodies as signaling metabolites. Trends Endocrinol Metab. 2014;25(1):42\u201352.","journal-title":"Trends Endocrinol Metab"},{"issue":"6116","key":"1056_CR21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1126\/science.1227166","volume":"339","author":"T Shimazu","year":"2013","unstructured":"Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, Le Moan N, Grueter CA, Lim H, Saunders LR, Stevens RD, Newgard CB, Farese RV Jr, de Cabo R, Ulrich S, Akassoglou K, Verdin E. Suppression of oxidative stress by \u03b2-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science. 2013;339(6116):211\u20134.","journal-title":"Science"},{"issue":"2","key":"1056_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.diabres.2014.08.009","volume":"106","author":"JC Newman","year":"2014","unstructured":"Newman JC, Verdin E. \u03b2-Hydroxybutyrate: much more than a metabolite. Diabetes Res Clin Pract. 2014;106(2):173\u201381.","journal-title":"Diabetes Res Clin Pract"},{"issue":"18","key":"1056_CR23","first-page":"5165","volume":"60","author":"LM Butler","year":"2000","unstructured":"Butler LM, Agus DB, Scher HI, Higgins B, Rose A, Cordon-Cardo C, Thaler HT, Rifkind RA, Marks PA, Richon VM. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. Cancer Res. 2000;60(18):5165\u201370.","journal-title":"Cancer Res"},{"issue":"4","key":"1056_CR24","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.freeradbiomed.2009.05.011","volume":"47","author":"Y Samuni","year":"2009","unstructured":"Samuni Y, Flores-Santana W, Krishna MC, Mitchell JB, Wink DA. The inhibitors of histone deacetylase suberoylanilide hydroxamate and trichostatin a release nitric oxide upon oxidation. Free Radic Biol Med. 2009;47(4):419\u201323.","journal-title":"Free Radic Biol Med"},{"key":"1056_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.freeradbiomed.2014.05.019","volume":"73","author":"Y Samuni","year":"2014","unstructured":"Samuni Y, Wink DA, Krishna MC, Mitchell JB, Goldstein S. Suberoylanilide hydroxamic acid radiosensitizes tumor hypoxic cells in vitro through the oxidation of nitroxyl to nitric oxide. Free Radic Biol Med. 2014;73:291\u20138.","journal-title":"Free Radic Biol Med"},{"issue":"28","key":"1056_CR26","doi-asserted-by":"crossref","first-page":"17174","DOI":"10.1016\/S0021-9258(17)44885-X","volume":"265","author":"M Yoshida","year":"1990","unstructured":"Yoshida M, Kijima M, Akita M, Beppu T. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin a. J Biol Chem. 1990;265(28):17174\u20139.","journal-title":"J Biol Chem"},{"key":"1056_CR27","doi-asserted-by":"publisher","first-page":"e884","DOI":"10.1038\/cddis.2013.416","volume":"4","author":"X Chen","year":"2013","unstructured":"Chen X, Xiao W, Chen W, Luo L, Ye S, Liu Y. The epigenetic modifier trichostatin a, a histone deacetylase inhibitor, suppresses proliferation and epithelial-mesenchymal transition of lens epithelial cells. Cell Death Dis. 2013;4:e884.","journal-title":"Cell Death Dis"},{"key":"1056_CR28","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1007\/s00018-007-7079-x","volume":"64","author":"G Rosenberg","year":"2007","unstructured":"Rosenberg G. The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees? Cell Mol Life Sci. 2007;64:2090\u2013103.","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"1056_CR29","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1161\/CIRCULATIONAHA.112.103176","volume":"126","author":"L Zhao","year":"2012","unstructured":"Zhao L, Chen C-N, Hajji N, Oliver E, Cotroneo E, Wharton J, Wang D, Li M, McKinsey TA, Stenmark KR, Wilkins MR. Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid (VPA) and suberoylanilide hydroxamic acid (SAHA). Circulation. 2012;126(4):455\u201367.","journal-title":"Circulation"},{"key":"1056_CR30","doi-asserted-by":"publisher","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","volume":"20","author":"M Gottlicher","year":"2001","unstructured":"Gottlicher M, Minucci S, Zhu P, Kramer OH, Schimpf A, Giavara S, Sleeman JP, Lo CF, Nervi C, Pelicci PG, Heinzel T. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J. 2001;20:6969\u201378.","journal-title":"EMBO J"},{"key":"1056_CR31","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ctrv.2007.11.003","volume":"34","author":"A Duenas-Gonzalez","year":"2008","unstructured":"Duenas-Gonzalez A, Candelaria M, Perez-Plascencia C, Perez-Cardenas E. de lC-H, Herrera LA. Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors. Cancer Treat Rev. 2008;34:206\u201322.","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"1056_CR32","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.numecd.2005.05.003","volume":"15","author":"D Rio Del","year":"2005","unstructured":"Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis. 2005;15(4):316\u201328.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"5","key":"1056_CR33","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1159\/000366364","volume":"34","author":"L Sun","year":"2014","unstructured":"Sun L, Zang WJ, Wang H, Zhao M, Yu XJ, He X, Miao Y, Zhou J. Acetylcholine promotes ROS detoxification against hypoxia\/reoxygenation-induced oxidative stress through FoxO3a\/PGC-1\u03b1 dependent superoxide dismutase. Cell Physiol Biochem. 2014;34(5):1614\u201325.","journal-title":"Cell Physiol Biochem"},{"issue":"5666","key":"1056_CR34","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1126\/science.1094637","volume":"303","author":"A Brunet","year":"2004","unstructured":"Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, Hu LS, Cheng HL, Jedrychowski MP, Gygi SP, Sinclair DA, Alt FW, Greenberg ME. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science. 2004;303(5666):2011\u20135.","journal-title":"Science"},{"issue":"2","key":"1056_CR35","first-page":"765","volume":"41","author":"J Song","year":"2018","unstructured":"Song J, Guo D, Bi H. Chlorogenic acid attenuates hydrogen peroxide-induced oxidative stress in lens epithelial cells. Int J Mol Med. 2018;41(2):765\u201372.","journal-title":"Int J Mol Med"},{"key":"1056_CR36","doi-asserted-by":"publisher","first-page":"788","DOI":"10.12659\/MSM.897630","volume":"22","author":"L Zhu","year":"2016","unstructured":"Zhu L, Zhao K, Lou D. Apoptosis factors of Lens epithelial cells responsible for Cataractogenesis in Vitrectomized eyes with silicone oil tamponade. Med Sci Monit. 2016;22:788\u201396.","journal-title":"Med Sci Monit"},{"issue":"6","key":"1056_CR37","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1159\/000447920","volume":"39","author":"Y Ji","year":"2016","unstructured":"Ji Y, Rong X, Li D, Cai L, Rao J, Lu Y. Inhibition of cartilage acidic protein 1 reduces ultraviolet B irradiation induced-apoptosis through P38 mitogen-activated protein kinase and Jun amino-terminal kinase pathways. Cell Physiol Biochem. 2016;39(6):2275\u201386.","journal-title":"Cell Physiol Biochem"},{"issue":"4","key":"1056_CR38","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1517\/17425255.2013.754011","volume":"9","author":"J Fraczek","year":"2013","unstructured":"Fraczek J, Vanhaecke T, Rogiers V. Toxicological and metabolic considerations for histone deacetylase inhibitors. Expert Opin Drug Metab Toxicol. 2013;9(4):441\u201357.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"2","key":"1056_CR39","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1159\/000369733","volume":"35","author":"Y Zheng","year":"2015","unstructured":"Zheng Y, Chen H, Yin M, Ye X, Chen G, Zhou X, Yin L, Zhang C, Ding B. MiR-376a and histone deacetylation 9 form a regulatory circuitry in hepatocellular carcinoma. Cell Physiol Biochem. 2015;35(2):729\u201339.","journal-title":"Cell Physiol Biochem"},{"key":"1056_CR40","doi-asserted-by":"publisher","first-page":"272","DOI":"10.2174\/156802609788085296","volume":"9","author":"D Rotili","year":"2009","unstructured":"Rotili D, Simonetti G, Savarino A, Palamara AT, Migliaccio AR, Mai A. Non-cancer uses of histone deacetylase inhibitors: effects on infectious diseases and \u03b2-hemoglobinopathies. Curr Top Med Chem. 2009;9:272\u201391.","journal-title":"Curr Top Med Chem"},{"issue":"3","key":"1056_CR41","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1159\/000464389","volume":"41","author":"JX Jin","year":"2017","unstructured":"Jin JX, Lee S, Taweechaipaisankul A, Kim GA, Lee BC. The HDAC inhibitor LAQ824 enhances epigenetic reprogramming and in vitro development of porcine SCNT embryos. Cell Physiol Biochem. 2017;41(3):1255\u201366.","journal-title":"Cell Physiol Biochem"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-019-1056-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12886-019-1056-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-019-1056-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T14:38:06Z","timestamp":1720967886000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-019-1056-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,4]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1056"],"URL":"https:\/\/doi.org\/10.1186\/s12886-019-1056-7","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,4]]},"assertion":[{"value":"12 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Professor Yi Lu is a member of the editorial board of BMC Ophthalmology.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"42"}}